Chronic Traumatic Encephalopathy Market is segmented By Drug Type (Small Molecule Drugs, Biologic Drugs), By Route of Administration (Oral, Injectable), By Stage of Development (Preclinical, Phase I, Phase II, Phase III), By Mechanism of Action (Neuroprotective Agents, Anti-inflammatory Drugs), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned.